Live Q&A: Pfizer Making Daily Pill for COVID-19; Taliban Declares China Its ‘Main Partner’
Pfizer announced that it’s in its phase two clinical trials of a daily pill taken orally to combat COVID-19. The company’s CEO, Albert Bourla, wrote on Twitter that to beat the virus, it will “likely require both vaccines [and] treatments.” And in other news, the Taliban has declared that China is its “main partner,” and hinted at future infrastructure programs under the Taliban-China partnership. In this live Q&A with Crossroads host Joshua Philipp we’ll discuss these stories and others, and answer questions from the audience.
Pfizer announced that it’s in its phase two clinical trials of a daily pill taken orally to combat COVID-19. The company’s CEO, Albert Bourla, wrote on Twitter that to beat the virus, it will “likely require both vaccines [and] treatments.” And in other news, the Taliban has declared that China is its “main partner,” and hinted at future infrastructure programs under the Taliban-China partnership. In this live Q&A with Crossroads host Joshua Philipp we’ll discuss these stories and others, and answer questions from the audience.
